The agenda covers exciting new therapies including bispecific antibodies, CAR-T therapies with a focus on indications, toxicities, and the role of collaboration in managing complex therapies in hematological diseases and other diseases. The event aims to explore the foundational aspects of bispecific therapy, cell, navigating the landscape in hematologic malignancies and beyond, shaping the future of oncology. It provides a concise platform for professionals to discuss current trends, challenges, and collaborative efforts in advancing cell in blood cancers and beyond.
FLASCO is co-partner of this program and does not manage this program directly. For more information or assistance, please contact the event organizers directly at jdevore2@kumc.edu.
Register here: https://www.eeds.com/live/427419
